Suggested remit - To appraise the clinical and cost effectiveness of pitolisant hydrochloride within its marketing authorisation for treating excessive daytime sleepiness caused by obstructive sleep apnoea
 
Status In progress
Process STA 2018
ID number 1065

Provisional Schedule

Expected publication 27 January 2021

Project Team

Project lead Emily Richards

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
09 December 2019 In progress, Referred: 19/03/2019
09 December 2019 The Department for Health and Social Care has asked NICE to conduct an appraisal of Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea. Please note that following on from advice received from the company the timelines for this appraisal have been revised. We now anticipate that the appraisal will begin during early-March 2020 when we will write to you about how you can get involved.
20 September 2018 - 18 October 2018 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance